Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ARG1 | P05089 | 5/20 | 0.36 |
| ▸ | ARG2 | P78540 | 5/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL348479 | 0.78 | MEN1 (0.54) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL168034 | 0.75 | ARG1 (0.46) | ALDH1A1ARG1ARG2 | |
| SCHEMBL12477487 | 0.72 | CYP2C19 (0.33) | ALDH1A1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL27995083 | 0.71 | NAAA (0.43) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL23010905 | 0.70 | ARG1 (0.48) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL6759253 | 0.69 | MEN1 (0.68) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL6759254 | 0.69 | MEN1 (0.68) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL24163861 | 0.69 | MEN1 (0.68) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL2015797 | 0.69 | ALDH1A1 (0.37) | ALDH1A1MEN1KMT2A | |
| SCHEMBL2013789 | 0.69 | ALDH1A1 (0.33) | ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012088597-A1 | NITRIC OXIDE AMINO ACID ESTERS FOR ENHANCEMENT OF PHYSICAL OR MUSCULAR PERFORMANCE AND THE TREATMENT OF MUSCULAR OR NEUROMUSCULAR DISEASES | ORAL DELIVERY TECHNOLOGY LTD. (CA) | 2012-07-05 | — | — | WO | claimed |
| WO-2012027827-A1 | NITRIC OXIDE AMINO ACID ESTERS FOR SKIN REJUVENATION | ORAL DELIVERY TECHNOLOGY LTD. (CA) | 2012-03-08 | — | — | WO | claimed |
| WO-2012027827-A1 | NITRIC OXIDE AMINO ACID ESTERS FOR SKIN REJUVENATION | ORAL DELIVERY TECHNOLOGY LTD. (CA) | 2012-03-08 | — | — | WO | disclosed |